About
MYi wants to revolutionize preventative and personalized medicine. Using a modular platform, MYi has the technology to analyze hundreds of molecules in a drop of blood, where those molecules are both identified and quantified using a consumer next-generation sequencing device. The obtained molecular information can be ported to a medical professional and then rerouted to the consumer as a medically curated report. As we leverage the multiplex and high-throughput nature of next-generation sequencing, we can analyze hundreds of different samples in parallel, drastically minimizing costs. With far reaching applications in cancer diagnostics, blood analyses, early disease detection, and precision medicine the potential for MYi to revolutionize medicine is high. Our vision at MYi aims to transform academic research, dramatically lower costs of routine blood tests in the clinic, and ultimately be the product consumers use for "at-home" preventative health.